Merck KGaA wants to get in early on Chinese innovation — so it's setting up a seed fund there
Merck KGaA is carving out a small — but emblematic — portion of its venture arm to nurture new Chinese startups while it cuts the ribbon on an innovation hub in Shanghai.
The €13 million (RMB100 million) seed fund falls within the scope of M Ventures’ €300 million mandate, according to the German drugmaker, and would be jointly managed by that team and the innovation hub. Startups that fall into the healthcare, life science, performance materials and “new businesses” buckets can expect to receive investments between €500,000 and €1 million designed to bring them over to a value inflection point within two years.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.